STOCKHOLDERS' EQUITY (Tables)

6 Months Ended

Jul. 31, 2025

Share-Based Payment Arrangement [Abstract]

Schedule of Components of Stock-based Compensation Expense

The components of stock-based compensation expense recognized in the condensed consolidated statements of operations consisted of the following (in thousands):

	Three Months Ended July 31,				Six Months Ended July 31,
	2025		2024		2025		2024
Cost of revenue	$	5,399	$	5,564	$	10,064	$	10,433
Research and development	24,289		20,811		45,230		38,276
Sales and marketing	21,338		18,882		44,253		36,956
General and administrative	22,858		19,420		43,028		37,565
Restructuring	—		—		(36)		—
Total	$	73,884	$	64,677	$	142,539	$	123,230

Schedule of Nonvested Restricted Stock Shares Activity

A summary of our RSU activity is as follows:

	Number of RSUs	Weighted-Average Grant Date Fair Value
Outstanding as of January 31, 2025	27,357,828	$	21.60
Granted	15,994,089	18.58
Released	(5,513,855)	22.12
Forfeited	(3,259,013)	20.40
Outstanding as of July 31, 2025	34,579,049	$	20.23

Schedule of Share-Based Payment Arrangement, Performance Shares, Activity

A summary of our PSU activity is as follows:

	Number of PSUs	Weighted-Average Grant Date Fair Value
Outstanding as of January 31, 2025	233,680	$	22.27
Granted	542,431	17.37
Released	(224,323)	22.26
Forfeited or cancelled	(9,357)	22.38
Outstanding as of July 31, 2025	542,431	$	17.37

Schedule of Share-based Payment Arrangement, Option, Activity

A summary of our stock option activity is as follows:

	Number of Options	Weighted-Average Exercise Price
Outstanding as of January 31, 2025	13,164,743	$	6.31
Exercised	(3,199,972)	4.76
Forfeited	(32,212)	2.18
Outstanding as of July 31, 2025	9,932,559	$	6.82
Vested and expected to vest as of July 31, 2025	9,932,559	$	6.82
Vested and exercisable as of July 31, 2025	7,814,249	$	6.14